Reported Jun 8, 2022 · Terminated
Anagrelide Capsules USP, 0.5 mg, 100-count bottles, Rx Only, Manufactured in India For: TEVA PHARMACEUTICALS USA, Inc.,…
Teva Pharmaceuticals USA Inc.
High riskUsing this product could cause serious injury, illness or death — stop using it now.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Teva Pharmaceuticals USA Inc · 400 Interpace Pkwy Bldg A · Parsippany, NJ · 07054-1120
Is this the product you have?
- Anagrelide Capsules USP, 0.5 mg, 100-count bottles, Rx Only
- Manufactured in India ForTEVA PHARMACEUTICALS USA, Inc., North Wales, PA 19454. NDC 0172-5241-60
- Lot codes and dates
Lot # GD01090Exp 05/2022
- Amount recalled
- 4224 cartons
Where it was sold
- Nationwide
Why it was recalled
Stop using this product now
Failed Dissolution Specifications- Low Out-Of-Specification results obtained during stability testing.
Using this product could cause serious injury, illness or death — stop using it now.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Teva Pharmaceuticals USA Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.